Apply Now to The Susan Skinner Memorial Fund Scholarship: Advancing Women’s Leadership in the Bleeding Disorders Field
The World Federation of Hemophilia (WFH) recently shared an announcement post on X:
”Applications for The Susan Skinner Memorial Fund scholarship program is now open! The scholarship encourages the active participation of women of all ages in the global Bleeding Disorders community through education, training and networking.”
To learn more, follow the link.
The Susan Skinner Memorial Fund scholarship supports the leadership and active engagement of women aged 18 to 60 within the global bleeding disorders community.
Awarded every two years to both U.S. and international applicants, the scholarship provides opportunities for education, training, and networking at major WFH events.
This year’s recipients will attend the WFH 2026 World Congress in Kuala Lumpur, gaining invaluable experience and connections to advance advocacy and care in inherited bleeding disorders.
The project aims to enhance the treatment and care for women and girls with bleeding disorders (WGBD) across local, national, and global communities.
Applications are now open for this transformative program and will be accepted from July 15 to September 15, 2025.
Do not miss the chance!
Discover more global scholarship opportunities in Hemostasis Today.
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?
-
Feb 26, 2026, 15:08Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
-
Feb 26, 2026, 15:03Gregory Piazza: Importance of Recognizing PE As A Wide Spectrum of Presentations and Greater Range of Adverse Outcomes
-
Feb 26, 2026, 14:57Abdulla A. Damluji: Sex As An Effect Measure Modifier Between Frailty and Outcomes in AMI Patients
-
Feb 26, 2026, 14:48Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban’s Role in LVT
-
Feb 26, 2026, 14:44Wolfgang Miesbach: Synovitis and Haemophilia in Focus at GTH2026
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals